Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Gilead Sciences Inc GILD

Sector: Healthcare | Sub-Sector: Biotechnology

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.
Price: $106.09 | Change: $-0.58 | %Change: -0.54%
Volume: 13.7m | Day High/Low: 107.00/104.075 | 52 Week High/Low: 110.64/63.50


Last Traded: October 22, 2014 12:00 Transaction Volume: 13.7m
Open: $106.09 Previous Close: $106.67
Bid: $106.20 Ask: $106.49
Bid Size: 300 Ask Size: 300
Market Cap: $160.4b Shares Out: 1.5b
PE Ratio: 23.9 Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • RE:S & P target has not changed Just as a reminder

    0 stars

    Hi Harjay, hope the S &P estimate will be on target.  It is supposed to be a reputable rating agency.  The biotech field related to...

    2 stars

  • Maybe a really good buy now

    0 stars

    Even Ford Equity Research has given it a "Strong Buy" Rating just a few days ago.  I don't know how good this rating agency is, as I only...

    2 stars

  • Parabolic

    0 stars

    SP starting to go parabolic & Technicals are in overbought territory. Time for a pullback to test breakout above $94. carlos

    2 stars

  • US GDP growth

    0 stars

    up more than expected (4%) which may have spooked the mkt, because it may mean to some investors'  that QE will end sooner & rates will...

    2 stars

  • S & P target has not changed Just as a reminder

    0 stars

    Stock Report | June 28, 2014 | NNM Symbol: GILD | GILD is in the S&P 500 Gilead Sciences Inc S&P Capital IQ Recommendation STRONG...

    3 stars